BIOMAT Database Logo BIOMAT Database Logo

Experiences with tolbutamide and chlorpropamide in tuberculous diabetic patients. 1959

F O SEGARRA, and D S SHERMAN, and B S CHARIF

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D002747 Chlorpropamide A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277) Clorpropamid,Apo-Chlorpropamide,Diabinese,Glucamide,Insogen,Meldian
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D014044 Tolbutamide A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Apo-Tolbutamide,Artosin,Diabetol,Diaval,Dolipol,Orabet,Orinase,Rastinon,Tolbutamid R.A.N.
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

F O SEGARRA, and D S SHERMAN, and B S CHARIF
[TREATMENT OF THE TUBERCULOUS AND DIABETIC WITH CHLORPROPAMIDE].
January 1964, La Semana medica,
F O SEGARRA, and D S SHERMAN, and B S CHARIF
Experiences with tolbutamide in a diabetic clinic.
July 1959, New York state journal of medicine,
F O SEGARRA, and D S SHERMAN, and B S CHARIF
Clinical studies with tolbutamide and chlorpropamide.
October 1960, New York state journal of medicine,
F O SEGARRA, and D S SHERMAN, and B S CHARIF
Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus.
January 1978, British medical journal,
F O SEGARRA, and D S SHERMAN, and B S CHARIF
Experiences with chlorpropamide, especially in the brittle diabetic.
March 1959, Annals of the New York Academy of Sciences,
F O SEGARRA, and D S SHERMAN, and B S CHARIF
Distribution of tolbutamide and chlorpropamide after administration to non-diabetic rats.
January 1971, European journal of pharmacology,
F O SEGARRA, and D S SHERMAN, and B S CHARIF
Clinical experiences with chlorpropamide, with special reference to comparison with previous experience with carbutamide and tolbutamide.
March 1959, Annals of the New York Academy of Sciences,
F O SEGARRA, and D S SHERMAN, and B S CHARIF
Studies with chlorpropamide in diabetic patients.
March 1959, Annals of the New York Academy of Sciences,
F O SEGARRA, and D S SHERMAN, and B S CHARIF
Use of chlorpropamide in diabetes mellitus in usual diabetic patients and in primary and secondary tolbutamide failures.
March 1959, Annals of the New York Academy of Sciences,
F O SEGARRA, and D S SHERMAN, and B S CHARIF
Advantages and disadvantages in shifting patients from tolbutamide to chlorpropamide.
March 1959, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!